{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T05:19:41Z","timestamp":1788067181157,"version":"build-2784847793"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":61,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP18dm0107071"],"award-info":[{"award-number":["JP18dm0107071"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP17dm0107071"],"award-info":[{"award-number":["JP17dm0107071"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20dm0107071"],"award-info":[{"award-number":["JP20dm0107071"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19dm0107071"],"award-info":[{"award-number":["JP19dm0107071"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23ym0126095h0002"],"award-info":[{"award-number":["23ym0126095h0002"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K06644"],"award-info":[{"award-number":["22K06644"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24KJ0359"],"award-info":[{"award-number":["24KJ0359"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22ym0126095h0001"],"award-info":[{"award-number":["22ym0126095h0001"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006004","name":"Tohoku University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006004","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.prdoa.2025.100313","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T20:56:36Z","timestamp":1741726596000},"page":"100313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Associations among blood biomarkers, clinical subtypes, and prognosis in Parkinson\u2019s disease"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2856-4233","authenticated-orcid":false,"given":"Hideki","family":"Oizumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kawahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Sekimori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Totsune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohji","family":"Fukunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.prdoa.2025.100313_b0005","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S1474-4422(16)30230-7","article-title":"The epidemiology of Parkinson's disease: risk factors and prevention","volume":"15","author":"Ascherio","year":"2016","journal-title":"The Lancet. Neurology"},{"issue":"6","key":"10.1016\/j.prdoa.2025.100313_b0010","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1136\/jnnp.51.6.745","article-title":"The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease","volume":"51","author":"Gibb","year":"1988","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"11","key":"10.1016\/j.prdoa.2025.100313_b0015","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"PNAS"},{"issue":"2","key":"10.1016\/j.prdoa.2025.100313_b0020","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/PL00007856","article-title":"The heterogeneity of idiopathic Parkinson's disease","volume":"249","author":"Foltynie","year":"2002","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.prdoa.2025.100313_b0025","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","article-title":"Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease","volume":"76","author":"De Pablo-Fernandez","year":"2019","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.prdoa.2025.100313_b0030","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/mds.29582","article-title":"Nuclear imaging data-driven classification of Parkinson's disease","volume":"38","author":"Totsune","year":"2023","journal-title":"Mov. Disord."},{"issue":"10","key":"10.1016\/j.prdoa.2025.100313_b0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"11","key":"10.1016\/j.prdoa.2025.100313_b0040","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/mds.28206","article-title":"Validation of serum neurofilament light chain as a biomarker of Parkinson's disease progression","volume":"35","author":"Mollenhauer","year":"2020","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.prdoa.2025.100313_b0045","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000105157","article-title":"Serum heart-type fatty acid-binding protein and cerebrospinal fluid tau: marker candidates for dementia with Lewy bodies","volume":"4","author":"Mollenhauer","year":"2007","journal-title":"Neurodegener Dis"},{"issue":"6","key":"10.1016\/j.prdoa.2025.100313_b0050","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.3390\/ijms21062230","article-title":"Fatty acid binding protein 3 enhances the spreading and toxicity of \u03b1-synuclein in mouse brain","volume":"21","author":"Yabuki","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.prdoa.2025.100313_b0055","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuropharm.2019.03.029","article-title":"Inhibition of MPTP-induced alpha-synuclein oligomerization by fatty acid-binding protein 3 ligand in MPTP-treated mice","volume":"150","author":"Matsuo","year":"2019","journal-title":"Neuropharmacology"},{"issue":"17","key":"10.1016\/j.prdoa.2025.100313_b0060","doi-asserted-by":"crossref","first-page":"13267","DOI":"10.3390\/ijms241713267","article-title":"Using fatty acid-binding proteins as potential biomarkers to discriminate between Parkinson's disease and dementia with lewy bodies: exploration of a novel technique","volume":"24","author":"Kawahata","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.prdoa.2025.100313_b0065","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jamaneurol.2015.1449","article-title":"Cerebrospinal fluid patterns and the risk of future dementia in early, incident Parkinson disease","volume":"72","author":"Backstrom","year":"2015","journal-title":"JAMA Neurol."},{"issue":"12","key":"10.1016\/j.prdoa.2025.100313_b0070","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.prdoa.2025.100313_b0075","doi-asserted-by":"crossref","DOI":"10.1007\/s00415-002-1301-4","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages)","author":"Braak","year":"2002","journal-title":"J. Neurol."},{"issue":"4","key":"10.1016\/j.prdoa.2025.100313_b0080","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00702-018-1898-9","article-title":"Is Braak staging valid for all types of Parkinson's disease?","volume":"126","author":"Jellinger","year":"2019","journal-title":"J. Neural Transm. (Vienna)"},{"issue":"11","key":"10.1016\/j.prdoa.2025.100313_b0085","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s10072-018-3522-z","article-title":"Disease progression in Parkinson subtypes: the PPMI dataset","volume":"39","author":"Aleksovski","year":"2018","journal-title":"Neurol. Sci."},{"issue":"2","key":"10.1016\/j.prdoa.2025.100313_b0090","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3233\/JPD-212866","article-title":"Serum neurofilament light chain as a marker of progression in Parkinson's disease: long-term observation and implications of clinical subtypes","volume":"12","author":"Rodstrom","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.prdoa.2025.100313_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106237","article-title":"Neurofilament light predicts worse nonmotor symptoms and depression in Parkinson's disease","volume":"185","author":"Urso","year":"2023","journal-title":"Neurobiol. Dis."},{"issue":"2","key":"10.1016\/j.prdoa.2025.100313_b0100","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00401-010-0711-0","article-title":"The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's Disease and Parkinson's Disease Dementia","volume":"120","author":"Schulz-Schaeffer","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"1","key":"10.1016\/j.prdoa.2025.100313_b0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JPD-150769","article-title":"Retrograde axonal degeneration in Parkinson disease","volume":"6","author":"Tagliaferro","year":"2016","journal-title":"J. Parkinsons Dis."},{"issue":"1","key":"10.1016\/j.prdoa.2025.100313_b0110","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"issue":"6701","key":"10.1016\/j.prdoa.2025.100313_b0115","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/26652","article-title":"The ubiquitin pathway in Parkinson's disease","volume":"395","author":"Leroy","year":"1998","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.prdoa.2025.100313_b0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/35086067","article-title":"Failure of the ubiquitin-proteasome system in Parkinson's disease","volume":"2","author":"McNaught","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"2","key":"10.1016\/j.prdoa.2025.100313_b0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/path.1711610210","article-title":"Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases","volume":"161","author":"Lowe","year":"1990","journal-title":"J. Pathol."},{"issue":"4","key":"10.1016\/j.prdoa.2025.100313_b0130","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-024-02886-y","article-title":"Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson's disease","volume":"30","author":"Pagano","year":"2024","journal-title":"Nat. Med."}],"container-title":["Clinical Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112525000179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590112525000179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:20:54Z","timestamp":1775820054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590112525000179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":26,"alternative-id":["S2590112525000179"],"URL":"https:\/\/doi.org\/10.1016\/j.prdoa.2025.100313","relation":{},"ISSN":["2590-1125"],"issn-type":[{"value":"2590-1125","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations among blood biomarkers, clinical subtypes, and prognosis in Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prdoa.2025.100313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100313"}}